Barriers and facilitators to buprenorphine use for opioid agonist treatment: protocol for a scoping review
Introduction In the context of the opioid crisis in North America, the benefits of evidence-based opioid agonist treatments such as buprenorphine/naloxone have not been optimised due to low uptake. Numerous factors contribute to the underuse of buprenorphine, and theory-informed approaches to identi...
Guardat en:
| Autors principals: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2019-12-01
|
| Col·lecció: | BMJ Open |
| Accés en línia: | https://bmjopen.bmj.com/content/9/12/e032285.full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|